Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 18.82
-0.06 (-0.32%)
Oct 15, 2026, 3:01 PM CET
Celon Pharma Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Celon Pharma stock has a consensus rating of "Sell" and an average price target of zł 20.38. The average 1-year stock price forecast is 8.29% higher than the current stock price, while the lowest is zł 16.00 (-14.98%) and the highest is zł 25.20 (+33.90%).
Price Target: zł 20.38 (+8.29%)
Analyst Consensus: Sell
Price Target
ChartAnalyst Ratings
The average analyst rating for Celon Pharma stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
281.43M
from 242.21M
Increased by 16.19%
Revenue Next Year
281.80M
from 281.43M
Increased by 0.13%
EPS This Year
-0.44
from -1.48
EPS Next Year
-0.31
from -0.44
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.